WallStSmart
SLNO

Soleno Therapeutics Inc

NASDAQ: SLNO · HEALTHCARE · BIOTECHNOLOGY

$52.78
+0.04% today

Updated 2026-04-29

Market cap
$2.73B
P/E ratio
135.33
P/S ratio
14.34x
EPS (TTM)
$0.39
Dividend yield
52W range
$29 – $90
Volume
3.8M

Soleno Therapeutics Inc (SLNO) Earnings

Quarterly earnings history, analyst estimates, and stock price reaction.

EPS beat streak
4 of 8
Last 8 quarters
Avg EPS surprise
+120.9%
Last 4 quarters
Revenue YoY growth
Most recent quarter
EPS YoY growth
+163.0%
Most recent quarter

Earnings surprise history (last 12 quarters)

Beat estimate Missed estimate

Quarterly EPS and revenue trend

Quarterly revenue EPS (diluted)

How the stock reacts to earnings

Avg 1-day reaction
-13.9%
Last 3 reports
Positive reaction rate
0%
0 of 3 quarters
Largest single-day move
-28.6%
2025-11-04
Report dateEPS actualSurpriseClose beforeClose after1-day reaction
2026-03-11$0.80+272.1%$40.61$36.74-9.5%
2025-11-04$0.47+840.0%$65.65$46.87-28.6%
2025-08-06$-0.09+85.9%$81.63$78.71-3.6%

Quarterly earnings history

Fiscal quarter endingEPS estimateEPS actualSurpriseRevenueYoY revenue
2025-12-31$0.22$0.80+272.1%$91.73M
2025-09-30$0.05$0.47+840.0%$66.02M
2025-06-30$-0.64$-0.09+85.9%$32.66M
2025-03-31$-0.93$-0.95-2.4%
2024-12-31$-1.08$-1.27-17.9%
2024-09-30$-0.63$-1.83-190.5%
2024-06-30$-0.60$-0.57+5.0%
2024-03-31$-0.37$-0.59-59.5%
2023-12-31$-0.27$-0.33-22.2%$3.45M
2023-09-30$-0.58$-0.95-63.8%
2023-06-30$-0.83$-0.81+2.4%
2023-03-31$-0.72$-0.88-22.2%

Frequently asked questions

Has Soleno Therapeutics Inc beaten earnings estimates?
Soleno Therapeutics Inc has beaten Wall Street EPS estimates in 4 of its last 8 quarterly reports, with an average EPS surprise of +120.9% over the last 4 quarters.
How does SLNO stock react to earnings?
SLNO stock has moved an average of -13.9% in the trading day following earnings over its last 3 reports, with positive reactions in 0% of those quarters.